Secondary efficacy endpoints included proportion of participants achieving body weight loss of 5% or more and 10% or more from baseline to week 24, change from baseline to week 24 in body weight, waist circumference and BMI, change from baseline to week 24 in glucose metabolism parameters (HbA1c, fasting plasma glucose and fasting insulin), changes from baseline to week 24 in cardiovascular risk factors (blood pressure, lipids [total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides]), changes from baseline to week 12 and week 24 in serum uric acid and ALT, changes in IWQOL-Lite scores, as well as changes from baseline to week 36 in body weight, waist circumference, BMI, glucose and cardio-metabolic risk factors
The timing of this side effect matters: sulfur burps typically emerge 37 days after your first dose or after a dose increase, peak around day 1014, and gradually fade as your digestive system acclimates to the medication
Techdirt.com
A patient on a weight loss drug like Wegovy may have one or more of them
[DOI] [PubMed] [Google Scholar] 51.Ren, J
